CW November 2004

category image Volume 13
Issue Number 11
November 2004
ISSN 10593802

Pancreatic Cancer Vaccine

A vaccine prepared from the protein overexpressed on pancreatic cancer cells can stimulate a patient?s own immune system to slow cancer growth. Phase I clinical study results show the vaccine to be safe and well-tolerated.
Go to Previous Page
Go to Next Page

Source & Additional Reading

Cancer Immunotherapy, September.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW November 2004

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login